Akèy › Twoub Konsomasyon Alkòl (AUD) › Maryland
Etid klinik pou Twoub Konsomasyon Alkòl (AUD) nan Maryland
24 etid pou Twoub Konsomasyon Alkòl (AUD) ap chèche patisipan nan sit nan Maryland.
Vil nan Maryland
Tèks ofisyèl etid la (Anglè)
Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving
- Behavioral Pharmacology Research Unit, Baltimore
Ap rekriteFaz 2/3
Laj 21 a 65 · Tout sèks · Mizajou Oct 2, 2026 · NCT07148843Hepatic Lipid Metabolism-Alcohol Use Disorder
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT07191561Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Oct 2, 2026 · NCT05677321Environment and Alcohol: A Pilot Study
- National Institute on Drug Abuse, Baltimore
Ap rekriteFaz 1Volontè an sante akeyi
Laj 21 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT06860607SMART-r: Substance Monitoring and Active Relapse Tracking Repository
- National Institute on Drug Abuse, Baltimore
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Oct 2, 2026 · NCT06676059Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT06484075A Study of Brenipatide in Participants With Alcohol Use Disorder
- Maryland Treatment Centers - Mountain Manor Treatment Center, Baltimore
- Maryland Treatment Centers - Avery Road Treatment Center, Rockville
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07219953A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
- Maryland Treatment Centers - Mountain Manor Treatment Center, Baltimore
- Maryland Treatment Centers - Avery Road Treatment Center, Rockville
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07219966Spironolactone in Alcohol Use Disorder (SAUD)
- National Institute on Drug Abuse, Baltimore
Ap rekriteFaz 1
Laj 21 a 99 · Tout sèks · Mizajou Sep 21, 2026 · NCT05807139PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Sep 18, 2026 · NCT06795581Characterization Imaging Instruments in Alcoholics and Non-Alcoholics
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT02108080Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 4
Laj 21 a 65 · Tout sèks · Mizajou Sep 3, 2026 · NCT06269627NIAAA Natural History Protocol
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Aug 31, 2026 · NCT02231840The Impact of Heavy Alcohol Use on Saliva and Oral Health
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Aug 28, 2026 · NCT06684483Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP
- National Institute on Drug Abuse, Baltimore
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Aug 24, 2026 · NCT06552741Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1
Laj 21 a 70 · Tout sèks · Mizajou Aug 17, 2026 · NCT07027839Tirzepatide in MetALD
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 2
Laj 21 a 100 · Tout sèks · Mizajou Aug 12, 2026 · NCT07046819Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1
Laj 21 a 65 · Tout sèks · Mizajou Jul 28, 2026 · NCT07559500Behavioral and Functional Task Development, Implementation, and Testing
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Jun 30, 2026 · NCT02108054COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study
- NIAAA Section on Human Psychopharmacology, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Jun 24, 2026 · NCT04391816Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH
- Johns Hopkins University School of Medicine, Baltimore
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 9, 2026 · NCT03845205Cerebellar Involvement in Alcohol Use Disorder (AUD)
- Johns Hopkins University School of Medicine, Baltimore
Ap rekriteVolontè an sante akeyi
Laj 25 a 55 · Tout sèks · Mizajou May 11, 2026 · NCT05732207A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects
- Johns Hopkins Bayview Medical Center, Baltimore
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Mar 31, 2026 · NCT05913752Alcohol Research in HIV: Relapse Prevention
- Johns Hopkins School of Medicine, Baltimore
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 18, 2026 · NCT05163301Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.